Skip to main content

Table 4 Levels of basic anthropometric and biochemical markers during intervention

From: Suppression of DNA/RNA and protein oxidation by dietary supplement which contains plant extracts and vitamins: a randomized, double-blind, placebo-controlled trial

Time (weeks)

 

0

4

8

ptrial

ptime

ptrial * ptime

BMI (kg/m2)

Placebo (N = 28)

26.6 ± 2.9

26.7 ± 3.0

26.7 ± 3.0

0.7

0.7

0.2

Supplement (N = 30)

27.0 ± 2.0

26.8 ± 2.0

26.8 ± 1.9

Systolic blood pressure (mm Hg)

Placebo (N = 28)

78.5 ± 8.8

74.0 ± 8.8

72.4 ± 8.2

0.8

0.1

0.1

Supplement (N = 30)

74.5 ± 8.5

75.3 ± 8.6

73.3 ± 8.4

Diastolic blood pressure (mm Hg)

Placebo (N = 28)

126.9 ± 10.2

120.2 ± 12.7

119.2 ± 9.7

0.8

0.1

0.2

Supplement (N = 30)

122.7 ± 10.5

117.4 ± 10.4

120.0 ± 7.4

Glucose (mmol/L)

Placebo (N = 28)

5.31 ± 0.56

5,27 ± 0.54

5.32 ± 0.63

0.09

0.3

0.1

Supplement (N = 30)

5.62 ± 0.71

5.63 ± 0.73

5.46 ± 0.69

Cholesterol (mmol/L)

Placebo (N = 28)

4.85 ± 1.11

4.71 ± 0.98

4.69 ± 1.07

0.1

0.06

0.9

Supplement (N = 30)

5.20 ± 1.09

5.10 ± 1.04

5.07 ± 1.11

HDL-chol (mmol/L)

Placebo (N = 28)

1.27 ± 0.37

1.23 ± 0.35

1.25 ± 0.35

0.4

0.3

0.6

Supplement (N = 30)

1.19 ± 0,41

1.17 ± 0.37

1.16 ± 0.37

LDL-chol (mmol/L)

Placebo (N = 28)

3.20 ± 1.13

3.12 ± 1.06

3.06 ± 1.17

0.1

0.2

0.9

Supplement (N = 30)

3.58 ± 1.18

3.53 ± 1.16

3.49 ± 1.18

Triacylglycerols (mmol/L)

Placebo (N = 28)

0.82 ± 0.44

0.83 ± 0.54

0.81 ± 0.46

0.1

0.6

0.1

Supplement (N = 30)

1.04 ± 0.73

0.97 ± 0.68

1.06 ± 0.78

Uric acid (mmol/L)

Placebo (N = 28)

0.28 ± 0.07

0.27 ± 0.07

0.28 ± 0.07

0.5

0.3

0.2

Supplement (N = 30)

0.27 ± 0.07

0.27 ± 0.06

0.27 ± 0.07

  1. Data are presented as means ± SD for normally distributed variables. Repeated measures ANOVA was used for the comparisons